Acadia Healthcare (ACHC) and Ensign Group (ENSG) on Torvanta's measures: ACHC grades higher on 0 of the 4 factor families and ENSG on 3.
| ACHC | ENSG | |
|---|---|---|
| Value grade | n/a | C+ |
| Growth grade | D | B- |
| Profitability grade | n/a | C+ |
| Momentum grade | C | C |
| Market value | n/a | $10.3B |
| P/E (trailing) | n/a | 27.7x |
| Forward P/E (Torvanta model estimate) | Subscribers | Subscribers |
| Revenue, last 12 months | $3.4B | $5.5B |
| Revenue growth (y/y) | n/a | +19% |
| Operating margin | 0.0% | 8.5% |
| Return on invested capital | n/a | 15.3% |
| Free-cash-flow yield | n/a | 5.9% |
| Total return, 1 year | +21.2% | -1.4% |
| Total return, 3 years | n/a | n/a |
Full ACHC analysis · Full ENSG analysis
Acadia Healthcare (ACHC) and Ensign Group (ENSG) on Torvanta's measures: ACHC grades higher on 0 of the 4 factor families and ENSG on 3. Which fits an investor depends on their goals; this is research, not a recommendation. Subscribers see where the model ranks each and its expected return.
On trailing earnings ACHC trades at n/a and ENSG at 27.7x; their value grades are n/a and C+ against their sectors.
Subscribers get a rating, a fair value estimate, a 12-month target and a risk read for every S&P 500 company, Torvanta's earnings estimates, and three model portfolios (Active, Adaptive and Patient) with every trade sized and explained. A free account includes 3 full Stock Analyst reports a month.
See plans Or get the free weekly newsletterTorvanta is research only - not investment advice and not a recommendation to buy or sell any security. Grades describe a company's reported data against its sector; they are not the model's view, change as data changes and can be wrong. Financial figures come from the company's SEC filings; returns include reinvested dividends. Past performance does not predict future results.
All stock ratings · Stock lists · AI stock research · Model portfolio · Research · Disclaimer